0 items USD 0.00Search
Your search for "gbi research pancreatic cancer therapeutics major developed markets 2021 strong late stage pipeline" gave back 1549430 results.
Transforming Growth Factor Beta 2 (BSC1 Cell Growth Inhibitor or Cetermin or Glioblastoma Derived T Cell Suppressor Factor or Polyergin or TGFB2) -...
Catalog:
Global Markets Direct
October 2018
Price: USD 3,500.00
Transforming Growth Factor Beta 2 (BSC1 Cell Growth Inhibitor or Cetermin or Glioblastoma Derived T Cell Suppressor Factor or Polyergin or TGFB2) -...
Catalog:
Global Markets Direct
April 2018
Price: USD 3,500.00
Heparanase - Drugs In Development, 2021 Summary Heparanase (Endo Glucoronidase or Heparanase 1 or HPSE or EC 3.2.1.166) pipeline Target constitutes...
Catalog:
Global Markets Direct
July 2021
Price: USD 3,500.00
Pancreatic Cancer - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
December 2018
Price: USD 2,500.00
Pancreatic Cancer - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
March 2020
Price: USD 2,500.00
Cyclin Dependent Kinase 2 - Pipeline Review, H2 2020 Summary Cyclin Dependent Kinase 2 (p33 Protein Kinase or Cell Division Protein Kinase 2 or CDK2...
Catalog:
Global Markets Direct
November 2020
Price: USD 3,500.00
Metastatic Pancreatic Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players Summary Metastatic Pancreatic Cancer...
Catalog:
Global Markets Direct
May 2022
Price: USD 2,500.00
CD40 Ligand - Pipeline Review, H2 2019 Summary CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Toll Like Receptor 3 (CD283 or TLR3) - Drugs in Development, 2021 Summary Toll Like Receptor 3 (CD283 or TLR3) pipeline Target constitutes close to...
Catalog:
Global Markets Direct
March 2021
Price: USD 3,500.00
Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - Pipeline Review, H1 2018 Summary Tyrosine Protein Kinase JAK1 (Janus Kinase 1...
Catalog:
Global Markets Direct
May 2018
Price: USD 3,500.00
Transforming Growth Factor Beta 1 (TGFB1) - Drugs in Development, 2021 Summary Transforming Growth Factor Beta 1 (TGFB1) - Transforming growth factor...
Catalog:
Global Markets Direct
March 2021
Price: USD 3,500.00
Pancreatic Cancer - Pipeline Review, H2 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
September 2020
Price: USD 2,500.00
5' Nucleotidase (Ecto 5' Nucleotidase or CD73 or NT5E or EC 3.1.3.5) - Drugs in Development, 2021 Summary 5' Nucleotidase (Ecto 5...
Catalog:
Global Markets Direct
November 2021
Price: USD 3,500.00
Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1 Associated Factor 1 or HDAC2 or EC 3.5.1.98) - Pipeline Review, H1 2018 Summary...
Catalog:
Global Markets Direct
March 2018
Price: USD 3,500.00
C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Drugs in Development, 2021 Summary C-C Chemokine Receptor Type...
Catalog:
Global Markets Direct
September 2021
Price: USD 3,500.00
